Evaluation of the Prevalence, the Diagnosis Tests, and the Associated Morbimortality of Sarcopenia in Hepatobiliary Surgery
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Sarcopenia
- Sponsor
- University Hospital, Angers
- Enrollment
- 45
- Locations
- 1
- Primary Endpoint
- the number of patients with a sarcopenia before having a hepatobiliary surgery mesured by impedancemetry and by the muscular force or the speed walking
- Status
- Terminated
- Last Updated
- 2 years ago
Overview
Brief Summary
The sarcopenia is defined as a loss of muscle mass and a loss of muscle function ( strength or performance). Some studies showed that the sarcopenia increase the postoperative complications and the overall survival in abdominal surgery. But the sarcopenia is not evaluated in the Hepatobiliary surgery. This prospective, monconcentrique study aim to evaluate the prevalence of sarcopenia, and its associated morbimortality in hepatobiliary surgery for malignant or benign tumors.
Investigators
Eligibility Criteria
Inclusion Criteria
- •hepatobiliary surgery
- •scheduled surgery
- •oral consent
Exclusion Criteria
- •pregnancy
- •patient under low protection
- •emergency surgery
- •hepatic encephalopathy stage II, III and IV
Outcomes
Primary Outcomes
the number of patients with a sarcopenia before having a hepatobiliary surgery mesured by impedancemetry and by the muscular force or the speed walking
Time Frame: 1 month
for the woman: i/impedancemetry BMI\<6,42kg/m2 and ii/muscular force \< 20kg or a walking speed \<0,8m/s
Secondary Outcomes
- comparison between the impedancemetry and the abdominopevis CT for the diagnosis of sarcopenia(3 months)
- comparison of the postoperatives complications using the clavien dindo classsification between the patient with sarcopenia and the patient without sarcopenia.(4 months)